Postdoc position in infectious disease epi, genomics, applied stats to join our work on sampling strategies for pathogen genomics surveillance. Based in Shirlee Wohl’s group at BWH but to work closely with my team. See ad here: massgeneralbrigham.wd1.myworkdayjobs.com/en-US/MGBExt...

BK. Titanji@boghuma.bsky.social · 4w ago

MMWR on Mpox surveillance in the US shows continuous local circulation during the last three years which suggests that it is transitioning towards endemic circulation in the United States www.cdc.gov/mmwr/volumes...

The genomic identity of early smallpox in South America www.science.org/doi/10.1126/...

BK. Titanji@boghuma.bsky.social · 2mo ago

Very important phase1/2 trial of a 6-valent group B strep vaccine. The vaccine was both safe and immunogenicity in pregnant and non pregnant persons. Sets the stage for ph3 studies. GBS sepsis is a major cause of neonatal sepsis causing 91,000 newborn deaths/yr. www.nature.com/articles/s41...

Meningococcal B vaccine ddi not prevent Gonorrhea in this RCT. It is a negative result but an important one which emphasizes the need for N. gonorrhoeae specific vaccines. We are seeing higher rates on gonococcal infections and more drug resistance globally. www.nejm.org/doi/full/10....

Meningococcal B Vaccine to Prevent Neisseria gonorrhoeae Infection | NEJM

No vaccines are currently licensed for the prevention of Neisseria gonorrhoeae infection. Observational studies suggest that the four-component meningococcal serogroup B vaccine (4CMenB) may reduce...

nejm.org

appreciate @stephanienolen.bsky.social and @carlzimmer.com ending the article with this important history on ebola drug access

Carl Zimmer@carlzimmer.com · 3mo ago

As the Bundibugyo outbreak continues to grow, researchers are scrambling to start clinical trials of antivirals and monoclonal antibodies to see if any work against the virus. Here's my story on the race, with @stephanienolen.bsky.social Gift link: nyti.ms/4eEZHqR

Look at that -- an mpox mRNA vaccine!! Tapping the sign, could we please have funding and appropriate regulation for mRNA vaccines back?

The Lancet Infectious Diseases@thelancetinfdis.bsky.social · 4mo ago

New Research Safety and immunogenicity of mRNA-based mpox vaccine candidate BNT166a: an open-label, dose-escalation, first-in-human trial www.thelancet.com/journals/lan...

Amazing speed from the teams in Uganda and the DRC - impressive! Three genomes released so far - a few quick takes: 1️⃣ New genomes ~equidistant from 2007 and 2012 outbreaks. 2️⃣ Represents new spillover from reservoir. 3️⃣ Limited diversity, so too early to speculate on timing. Great work ⭐!

Kristian G. Andersen@kgandersen.bsky.social · 4mo ago

virological.org/t/initial-ge...

A new Lancet study just reported the primary mortality analysis from the RTS,S malaria vaccine implementation programme in Ghana, Kenya, and Malawi. The verdict after 46 months is 1 in 8 deaths averted in eligible children, a very important outcome. www.thelancet.com/journals/lan...

Impact of introducing RTS,S/AS01E malaria vaccine on mortality in young children in Ghana, Kenya, and Malawi: an observational evaluation of a cluster-randomised implementation programme

Introduction of the RTS,S malaria vaccine in routine immunisation programmes was associated with a significant reduction in mortality in young children, averting about one in eight deaths, in areas wi...

thelancet.com

The Andes variant has been sequenced and publically shared. I leave it to virologists to dissect this first. virological.org/t/co... 1/2

Complete sequence of Orthohantavirus andesense virus: Swiss resident 2026

Posted on behalf of the Swiss National Reference Center for Emerging Viral Infections, Geneva University Hospitals and the Institute of Medical Virology, University of Zurich (Partner Laboratory National Reference Center for Emerging Viral Infections). On 5 May 2026, the Swiss National Reference Center for Emerging Viral Infections (Geneva University Hospitals) confirmed a case of Andes strain in a Swiss resident who had travelled on the MV Hondius cruise ship. The virus was sequenced from bloo...

virological.org

What we choose to implement - and when - matters. Our work shows that proactive screening strategies can reduce transmission by ~40% vs reactive responses. A key lesson for preparedness. In PNAS Nexus: ow.ly/cLnu50YCrcn

Proactive vs. reactive COVID-19 screening in schools: Lessons from experimental protocols in France during the Delta and Omicron waves

Abstract. The COVID-19 pandemic prompted diverse policies to manage safety in schools, balancing transmission control with educational continuity. We evalu

ow.ly

PNAS Nexus@pnasnexus.org · 6mo ago

A study of 25 primary schools in France found that weekly screening of all students during the Delta and Omicron waves of the COVID-19 pandemic reduced school transmission by around 40% compared to reactive strategies used at other schools. In PNAS Nexus: https://ow.ly/jhii50YCrcm

Congratulations to Miguel Paredes, Ph.D. Epidemiology; M.D. Medicine, on being named to the 2026 Husky 100. His work on infectious disease spread, health equity and community-centered care reflects the very best of UW. #Husky100 https://bit.ly/4vyFDwL

Honored to be a part of the #Husky100 this year!

University of Washington School of Public Health@uwsph.bsky.social · 5mo ago

Congrats to the 9 School of Public Health students who were selected to the 2026 #Husky100! Their dedication, leadership and enthusiasm inspires others to shape their own meaningful Husky experience. Learn more: sph.washington.edu/news-events/... #PublicHealth

The CDC has paused testing for rabies and pox viruses, the family of viruses that includes smallpox and mpox — and by July will have no experts to advise states on clinical aspects of the diseases Gift link: www.nytimes.com/2026/04/01/h...

C.D.C. Pauses Testing for Rabies and Mpox

nytimes.com

Excited to share our work w/ @justinlessler.bsky.social, Trevor Bedford & Amanda Perofsky: doi.org/10.1098/rspb.... We investigate when sequence datasets are informative about between-group transmission, and how this depends on the relative pace of mutation, between-group transmission and sampling.

Pediatricians contending with a sharp rise in vaccine hesitancy are trying to stay sensitive and supportive, even as they bear the brunt of parents’ mistrust and confusion. Gift link: www.nytimes.com/2026/03/11/h...

In Talking to Parents About Vaccines, Pediatricians Navigate a Sea of Misinformation

nytimes.com

On the cover of The Lancet: Editorial — “Robert F Kennedy Jr: 1 year of failure” Read the latest issue: spkl.io/63327Aa31W

The full results of the STOMP trial are now published in @nejm.org Tecovirimat did not shorten time to symptom resolution or impact symptoms of clade II mpox. The findings are similar to PALM007 trial which found no beneficial effects of the drug for clade I mpox www.nejm.org/doi/full/10....

Tecovirimat for the Treatment of Mpox | NEJM

Tecovirimat is approved for smallpox treatment under the Food and Drug Administration Animal Rule on the basis of efficacy in nonhuman primate models of mpox (previously known as monkeypox). Howeve...

nejm.org

Brilliant plenary on STI trends at #CROI2026. DoxyPEP implementation in Seattle shows indirect reductions of syphilis rates in cisgender women who are not the target group for the intervention. Shared sexual networks with men who are the target intervention group?

I use this (overly simplified) schematic to explain to folks why maintaining high measles immunity is so hard. Even with 100% coverage, you get different outcomes depending on who and when you vaccinate. Consider a population with more kids than adults -- start with them all being susceptible.

COVID-19 vaccination status during pregnancy and preeclampsia risk: the pandemic-era cohort of the INTERCOVID consortium www.thelancet.com/journals/ecl...

COVID-19 vaccination status during pregnancy and preeclampsia risk: the pandemic-era cohort of the INTERCOVID consortium

COVID-19 vaccination with a booster reduces the odds of PE by 30% approaching 60% reduction among women with pre-existing morbidities.

thelancet.com

Our Cutaneous Leishmaniasis cohort study in Ethiopia now out. Most patients received Sodium Stibogluconate but we show this has an extremely low cure rates at end of treatment. This data underpins our @globalhealthedctp3.bsky.social Multi-Arms-Multi-Stage trial to improve CL treatment.

Clinical and patient-reported outcomes of cutaneous leishmaniasis treatment in Ethiopia: A prospective, observational cohort study in two referral hospitals

We ran a prospective cohort of patients with cutaneous leishmaniasis patients in Ethiopia. Regardless of treatment choice we observed poor cure rates at 90

academic.oup.com

Oh my GOD King County Public Health is just wilding out for Valentines Day (and a lovely one).

#Mpox: recombinant virus with genomic elements of clades Ib and IIb - Global www.who.int/emergencies/...

The real story about statin safety from >122,000 RCT participants with individual level data. They can cause new-onset diabetes and muscle pain/weakness, but other than that they are remarkably safe for 62 outcomes. Rare liver function test abnormalities thelancet.com/journals/lan...

Assessment of adverse effects attributed to statin therapy in product labels: a meta-analysis of double-blind randomised controlled trials

Adverse event data from blinded randomised trials do not support causal relationships between statin therapy and most of the conditions (including cognitive impairment, depression, sleep disturbance, ...

thelancet.com

“What we found is there’s no significant excess risk with statins for almost all the conditions listed in statin packaging as potential side effects… We now have really good evidence that although these things may well happen to people while they take statins, that statins are not the cause”

Statins don’t cause most of the side effects on package warnings, study finds

Many people who should be taking statins avoid them for fear of side effects. A large new study says most of those side effects don't actually show up.

statnews.com

Oh boy. “The University of Florida and the Florida Department of Health in Alachua County are investigating potential measles exposure in two UF classes following two confirmed cases in the county. Health officials have begun contacting individuals who may have been exposed.” @aetiology.bsky.social

Measles exposure reported in two University of Florida classes, university says

The University of Florida and the Florida Department of Health in Alachua County are investigating potential measles exposure in two UF classes following two confirmed cases in the county.

news4jax.com

Mpox cohorts from NYC and Houston. Conclusion: Post-mpox sequelae frequently persisted 11 to 18 months after acute mpox, with limited body distribution or physical morbidity but with continued social and sexual effects. www.acpjournals.org/doi/10.7326/... #IDSky

Long-Term Mpox Sequelae 11 to 18 Months After Acute Illness: A Cohort Study in Two U.S. Cities: Annals of Internal Medicine: Vol 0, No 0

Background: Little was known about persistent sequelae of mpox before the 2022 multinational clade II mpox virus outbreak. Objective: To characterize post-mpox sequelae 11 to 18 months after acute mpo...

acpjournals.org

The NIRSE-GAL study looking at real world impact of nirsevimab in infants in Spain. Of 12 492 eligible infants, 94·4% received immunization. RSV-related LRTI hospitalisations decreased by 85·9% in the 1st season and 55·3% in the 2nd. www.thelancet.com/journals/lan... #IDSky

Impact of universal nirsevimab prophylaxis in infants on hospital and primary care outcomes across two respiratory syncytial virus seasons in Galicia, Spain (NIRSE-GAL): a population-based prospective...

Universal infant nirsevimab prophylaxis markedly reduced RSV-related hospitalisations and outpatient morbidity, with sustained reductions in RSV-related LRTI hospitalisations into the second season an...

thelancet.com